Brinkmann Joep F F, Abumrad Nada A, Ibrahimi Azeddine, van der Vusse Ger J, Glatz Jan F C
Cardiovascular Research Institute Maastricht (CARIM), Department of Physiology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
Biochem J. 2002 Nov 1;367(Pt 3):561-70. doi: 10.1042/BJ20020747.
Long-chain fatty acids are an important source of energy for several cell types, in particular for the heart muscle cell. Three different proteins, fatty acid translocase (FAT)/CD36, fatty acid transport protein and plasma membrane fatty acid binding protein, have been identified as possible membrane fatty acid transporters. Much information has been accumulated recently about the fatty acid transporting function of FAT/CD36. Several experimental models to study the influence of altered FAT/CD36 expression on fatty acid homoeostasis have been identified or developed, and underscore the importance of FAT/CD36 for adequate fatty acid transport. These models include the FAT/CD36 null mouse, the spontaneously hypertensive rat and FAT/CD36-deficient humans. The fatty acid transporting role of FAT/CD36 is further demonstrated in mice overexpressing muscle-specific FAT/CD36, and in transgenic mice generated using a genetic-rescue approach. In addition, a wealth of information has been gathered about the mechanisms that regulate FAT/CD36 gene expression and the presence of functional FAT/CD36 on the plasma membrane. Available data also indicate that FAT/CD36 may have an important role in the aetiology of cardiac disease, especially cardiac hypertrophy and diabetic cardiomyopathy. This review discusses our current knowledge of the three candidate fatty acid transporters, the metabolic consequences of alterations in FAT/CD36 levels in different models, and the mechanisms that have been identified for FAT/CD36 regulation.
长链脂肪酸是多种细胞类型,尤其是心肌细胞的重要能量来源。三种不同的蛋白质,即脂肪酸转位酶(FAT)/CD36、脂肪酸转运蛋白和质膜脂肪酸结合蛋白,已被确定为可能的膜脂肪酸转运体。最近积累了许多关于FAT/CD36脂肪酸转运功能的信息。已经确定或开发了几种实验模型来研究FAT/CD36表达改变对脂肪酸稳态的影响,并强调了FAT/CD36对充分的脂肪酸转运的重要性。这些模型包括FAT/CD36基因敲除小鼠、自发性高血压大鼠和FAT/CD36缺陷的人类。FAT/CD36在过表达肌肉特异性FAT/CD36的小鼠以及使用基因拯救方法产生的转基因小鼠中,其脂肪酸转运作用得到了进一步证明。此外,已经收集了大量关于调节FAT/CD36基因表达的机制以及质膜上功能性FAT/CD36存在情况的信息。现有数据还表明,FAT/CD36可能在心脏病,尤其是心脏肥大和糖尿病性心肌病的病因学中起重要作用。本综述讨论了我们目前对三种候选脂肪酸转运体的了解、不同模型中FAT/CD36水平改变的代谢后果以及已确定的FAT/CD36调节机制。